Abreos Biosciences is planning to develop a novel therapeutic for treatment of multiple sclerosis, a chronic neurological disease. Our approach will be to study a well characterized biologic in a new indication facilitated by our platform for precision personalized dosing.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Integrated Therapeutic for Multiple Sclerosis
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):